Actively Recruiting

Age: 18Years +
All Genders
NCT07309445

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Led by Janssen Research & Development, LLC · Updated on 2026-05-08

150

Participants Needed

1

Research Sites

179 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer occur again (disease-free survival) in participants with non-muscle invasive bladder cancer (NMIBC; an early-stage bladder cancer that is limited to the inner lining of bladder).

CONDITIONS

Official Title

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Has a confirmed diagnosis of NMIBC based on TURBT or cold cup biopsy
  • Started first dose of TAR-200 within 6 weeks before baseline visit
  • Participants with childbearing potential must follow contraceptive recommendations and consult their physician
  • Must provide informed consent as described in the protocol
Not Eligible

You will not qualify if you...

  • Has any medical condition that the health care practitioner considers a contraindication to TAR-200
  • Discontinued previous TAR-200 treatment before baseline visit
  • Previously received TAR-200 intravesically as part of a clinical trial
  • Received more than 2 doses or cycles of TAR-200 in the real-world setting
  • Currently participating in another interventional bladder cancer clinical trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Arkansas Urology

Little Rock, Arkansas, United States, 72211

Actively Recruiting

Loading map...

Research Team

S

Study Contact

CONTACT

E

Eliza M. Raymundo, MD, DMCC, FPUA, FPCS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here